A clinical trial to study the effects of two fluids, normal saline and albumin in patients with severe dengue fever
Not Applicable
- Conditions
- Health Condition 1: null- with severe dengue fever
- Registration Number
- CTRI/2018/03/012781
- Lead Sponsor
- Dr Suchitra Ranjit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients with severe dengue in critical phase
Exclusion Criteria
Infants and children admitted to the HDU/PICU with Severe Dengue with
a.Significant bleeding or drop in Hct requiring transfusion
b.Need for positive pressure ventilation ( NIV or invasive ventilation) at presentation to PICU
c.Co-infections: Bacterial sepsis, scrub
d.Patients who were fluid resuscitated prior to arrival
e.Admission in recovery phase of dengue
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Need for rescue colloids <br/ ><br>2.Need for ventilation (NIV/invasive ventilation) <br/ ><br>3.Organ failure <br/ ><br>4.Mortality <br/ ><br>Timepoint: on day 1 , 2 and 3 of admission and starting the fluid therapy <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Need for diuretic/hemo-dialysis/CRRT <br/ ><br>2.Duration of positive pressure <br/ ><br>3.Duration of PICU, Hospital stay <br/ ><br>Timepoint: during the period of hospitalization